lanthanum carbonate has been researched along with thyroxine in 1 studies
| Studies (lanthanum carbonate) | Trials (lanthanum carbonate) | Recent Studies (post-2010) (lanthanum carbonate) | Studies (thyroxine) | Trials (thyroxine) | Recent Studies (post-2010) (thyroxine) |
|---|---|---|---|---|---|
| 390 | 87 | 218 | 38,989 | 1,410 | 6,550 |
| Protein | Taxonomy | lanthanum carbonate (IC50) | thyroxine (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 2.1939 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 5.25 | |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 8 | |
| Bile acid receptor | Homo sapiens (human) | 7.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, HE; Ginsburg, KC; Weitzman, SP | 1 |
1 trial(s) available for lanthanum carbonate and thyroxine
| Article | Year |
|---|---|
Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine.
Topics: Adult; Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Interactions; Female; Humans; Lanthanum; Male; Thyrotropin; Thyroxine | 2009 |